PreSize Net medical device software for realistic surgery planning: next-generation scalable technology for selecting the best surgical scenario for every patient

我们的目标是使心血管手术更加高效和安全。该项目增强了我们的PreSize医疗设备软件的功能，这是一种新颖的临床决策支持解决方案，可帮助外科医生通过真实的手术模拟来计划和排练血管内植入物的放置。使用尖端的计算模型，我们充分利用可用的患者扫描和设备力学来准确预测每个患者血管解剖内设备的行为。这使得临床医生可以为每个病人选择最好的设备，减少并发症的数量和医院和社会的相关手术成本。该项目的特别创新之处在于，PreSize平台将尽可能易于使用，旨在最大限度地扩大其在整个医疗保健系统中的覆盖范围和效益。我们是一家屡获殊荣的初创公司，专门将这项技术引入医院。我们拥有一支强大的工程、软件、商业、法律和监管专家团队，之前得到了Innovate UK拨款的支持（目前运行BMC早期阶段奖，直到2022年4月），并得到了皇家工程院的持续支持。我们之前项目的成果获得了众多奖项，包括：* 2017年健康企业东部（HEE） NHS创新奖*《连线》杂志“2018年最佳医疗保健初创企业”* 2021年生物医学工程创新奖，以表彰我们的创始人“开创性的工作，导致了支持医疗干预的新技术”。我们还被选为伦敦数字健康加速器计划的一部分。曾是飞利浦医疗保健加速器评选的全球6家初创企业之一，并在《福布斯》（“创始人努力改变世界”）、《连线》（“从人工智能医生到3D x射线，医疗保健的未来已经到来”）以及《泰晤士报》、《金融时报》、《每日电讯报》等媒体上有过报道。我们的目标是将Oxford Heartbeat发展成为临床决策支持工具的领先提供商。促进英国经济及其在医疗保健领域的国际领导地位，改善所有人的医疗保健，并定义未来的医学。

Our goal is to make cardiovascular surgeries more efficient and safe. This project increases the power of our PreSize medical device software - a novel clinical decision-support solution that helps surgeons plan and rehearse implant placements inside blood vessels with realistic surgery simulations. Using cutting-edge computational modelling, we make the best use of available patient scans and device mechanics to accurately predict the behaviour of devices inside each patient's vessel anatomy. This allows clinicians to select the best device for every patient, reducing the number of complications and associated cost of surgeries for hospitals and our society. What is especially innovative with this project is that the PreSize platform will be developed to be as easily accessible as possible, aimed to maximise its reach and benefits across the healthcare system.We are an award-winning start-up company specifically created to bring this technology to hospitals. With a strong team of engineering, software, commercial, legal and regulatory experts, we have been previously supported by Innovate UK grants (currently running BMC Early Stage award until April 2022) and receive ongoing support by The Royal Academy of Engineering. The results of our previous projects have received numerous awards, including:* NHS Innovation Award 2017 from Health Enterprise East (HEE)* "Best Healthcare Start-up of 2018" by WIRED magazine* BioMedEng Innovation Prize 2021 for recognition of our founder's 'ground-breaking work which has led to new technologies that support medical interventions'We were also selected to be part of the Digital Health London Accelerator programme, and were previously one of the 6 startups selected globally by Philips Healthcare Accelerator, as well as featured in the general press, e.g., in Forbes ("Founders striving to change the world") and WIRED ("From AI doctors to 3D X-rays, the future of healthcare is already here"), as well as The Times, Financial Times, The Telegraph, etc.Our aim is to grow Oxford Heartbeat to become the leading provider of clinical decision support tools, to boost the UK economy and its international leadership in healthcare, to improve healthcare for all, and define the medicine of tomorrow.